Keywords: ضدافسردگی; Anxiety disorders; Perinatal period; Treatment; Antidepressant; Cognitive-behavioural therapy;
مقالات ISI ضدافسردگی (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: ضدافسردگی; Sodium butyrate; Chronic unpredictable mild stress (CUMS); 5-HT; BDNF; Blood-brain barrier (BBB); Antidepressant;
Keywords: ضدافسردگی; Individual differences; Antidepressant; Amphetamine; Striatum; Dopamine; Serotonin;
Keywords: ضدافسردگی; MI; myocardial infarction; SSRI; selective serotonin reuptake inhibitor; LPS; lipopolysaccharide; IL; interleukin; MMP; matrix metalloproteinase; TIMP; tissue inhibitor of metalloproteinase; CIT; citalopram; LAD; left anterior descending coronary artery;
Keywords: ضدافسردگی; Remission; Response; Depression; Antidepressant; Predictors;
Keywords: ضدافسردگی; Antidepressant; Brain bioenergetics; Creatine monohydrate; Major depressive disorder; Network organization; Selective serotonin reuptake inhibitor;
Keywords: ضدافسردگی; Depression; Outcome; Antidepressant; Prediction; Machine learning; Statistical learning;
Keywords: ضدافسردگی; older adults; antidepressant; treatment-resistant depression; patient perspectives;
Keywords: ضدافسردگی; Depression; Antidepressant; Suicide; Suicidal events; Adolescents; Young adults; Clinical trials;
Keywords: ضدافسردگی; Depression; Treatment resistant depression; Antidepressant; Predictors;
Keywords: ضدافسردگی; Duloxetine; Seizures; SNRI; Antidepressant; Anticonvulsant; Oxidative stressCS, convulsive seizures; PTZ, pentylenetetrazol; SSRIs, selective serotonin reuptake inhibitors; SNRIs, serotonin and norepinephrine reuptake inhibitors; EEG, electroencephalogram
Keywords: ضدافسردگی; Isoquinoline; Antidepressant; Chronic unpredictable mild stress; Inflammation; BDNF; Serotonin
Keywords: ضدافسردگی; Antidepressant; SSRI; Environment; Major depression; Plasticity; Serotonin; Undirected susceptibility to change hypothesis; Microglia; Inflammation; Cytokines;
Keywords: ضدافسردگی; Melatonin; Adult neurogenesis; Luzindole; Hippocampus; Doublecortin; Antidepressant;
Keywords: ضدافسردگی; Stress reactivity; Animal model; Depression; Antidepressant; Neuronal ensemble; Hippocampus;
Keywords: ضدافسردگی; Magnetic resonance imaging; Depression; Fetal development; Diffusion tensor imaging; Infant, Newborn; Antidepressant;
Keywords: ضدافسردگی; Ketamine; Serotonin; Antidepressant; Glutamate; Pharmacology
Keywords: ضدافسردگی; Deep brain stimulation; Olfactory bulbectomy; Antidepressant; Serotonin; Glutamate;
Keywords: ضدافسردگی; Antidepressant; Antipsychotic; Insomnia; Sedation; Adverse effects; Sleep; Somnolence;
Keywords: ضدافسردگی; Antidepressant; Serotonin reuptake inhibitor; Selective serotonin reuptake inhibitor; Bleeding; Postpartum hemorrhage; Intracranial hemorrhage; Nonsteroidal anti-inflammatory drugs; Antiplatelet drugs;
Keywords: ضدافسردگی; γ-Hydroxybutyrate; Liquid ecstasy; Prosocial; Prosexual; Antidepressant; Altruism
Keywords: ضدافسردگی; Antidepressant; Antipsychotic; Insomnia; Sedation; Adverse effects; Sleep; Somnolence;
Keywords: ضدافسردگی; SSRI; selective serotonin reuptake inhibitor; ASD; Autism spectrum disorder; OR; odds ratios; CI; confidence intervals; MOOSE; meta-analysis of observational studies in epidemiology; PRISMA; preferred reporting items for systematic reviews and meta-analys
Keywords: ضدافسردگی; BDNF; brain-derived neurotrophic factor; ECS; electroconvulsive seizure; ECT; electroconvulsive therapy; GTPase; guanidine triphosphatase; PBS; phosphate buffered saline; Electroconvulsive seizure; Autophagy; Endocytosis; Antidepressant; Neural plasticity
Keywords: ضدافسردگی; Therapeutic drug monitoring; Antipsychotic; Antidepressant; Psychopharmacology; Psychiatry; Psychopharmacotherapy; Pharmacokinetics; HPLC; Mass spectrometry; LC-MS/MS; ABCB1; ATP-binding cassette sub-family B member 1; AGNP; Arbeitsgemeinschaft für Neuro
Keywords: ضدافسردگی; antenatal depression; antenatal exposure to antidepressant; antenatal exposure to selective serotonin reuptake inhibitor; antidepressant; collaborative care; depression in pregnancy; in utero exposure to antidepressant; in utero exposure to selective sero
Keywords: ضدافسردگی; Venlafaxine; Stroke; Neuroprotection; Antidepressant; FGF2; BDNF; TGF-β1; Sensorimotor recovery;
Keywords: ضدافسردگی; Depression; Antidepressant; Response; Expectation; Suggestibility; Placebo;
Keywords: ضدافسردگی; DUD; duration of untreated depression; DUI; Duration of Untreated Illness; DUE; Duration of Untreated Episode; FED; first-episode depression; RED; recurrent episode of depression; Depression; Untreated illness; Antidepressant; Prevention; Early interventi
Keywords: ضدافسردگی; Antidepressant; Driving; SDLP; Positive control; Mirtazapine (PubChem CID: 4205);
Keywords: ضدافسردگی; Patient-centered care; Chronic heart failure; Depressive symptoms; Psycho-social treatment; Antidepressant; Psychotherapy;
Keywords: ضدافسردگی; ECT; ECS; Hippocampus; Neurogenesis; Neuroplasticity; Antidepressant;
Keywords: ضدافسردگی; Antidepressant; Anxiolytic; Exercise; Physical activity; Randomized controlled study; Cancer
Keywords: ضدافسردگی; methadone; methadone maintenance treatment; formulation; opioid maintenance treatment; ATD; antidepressant; BZD; benzodiazepine; Cg; capsule group; FGHIS; French General Health Insurance System; MMT; methadone maintenance treatement; OMT; opioid maintenac
Keywords: ضدافسردگی; Antidepressant; Bipolar disorder; Depression; HDRS; Ketamine; Ratings;
Keywords: ضدافسردگی; Depression; Antidepressant; Rat; Nitric oxide; Nitric oxide synthase
Keywords: ضدافسردگی; Sweden; Register-based cohort study; Antidepressant; Anxiolytics; Medication; Stress resilience;
Keywords: ضدافسردگی; Antidepressant; Emotion regulation; Emotion; fMRI; Serotonin; Functional connectivity
Keywords: ضدافسردگی; Bipolar II disorder; Bipolar II depression; Venlafaxine; Lithium; Antidepressant; Mood conversion; Relapse-prevention; Clinical trial. ClinicalTrials.gov identifier: NCT00602537;
Keywords: ضدافسردگی; Status epilepticus; Drug-induced seizure; Antidepressant; Antibiotic; Overdose; Treatment;
Keywords: ضدافسردگی; IGF2; Depression; Antidepressant; ERK1/2; Hippocampus;
Keywords: ضدافسردگی; Sleep; Major depressive disorder; Insomnia; Hypersomnia; Cognitive behavioral therapy; Hypnotic; Antidepressant;
Keywords: ضدافسردگی; Depressive symptoms; physical decline; hospitalization; antidepressant; nursing home; Hong Kong;
Keywords: ضدافسردگی; S-Adenosyl methionine; SAMe; Omega-3; Antidepressant; Nutraceutical; Nutrient; Depression; RCT; Protocol
Keywords: ضدافسردگی; Bipolar disorder; Diffusion tensor imaging; Chronotherapeutics; Antidepressant; Biomarker; White matter;
Keywords: ضدافسردگی; Prenatal environment; Antidepressant; Serotonin-selective reuptake inhibitors (SSRIs); Proinflammatory cytokines; Sickness behavior; Lipopolysaccharide (LPS)
Keywords: ضدافسردگی; Antidepressant; Depression; Old age; Psychotherapy
Keywords: ضدافسردگی; antidepressant; cost effectiveness analysis; economic evaluation; Markov model; microsimulation; repetitive transcranial magnetic stimulation;
Keywords: ضدافسردگی; Antidepressant; Cognitive decline; Neurodegeneration; Species-specific; Animal model; Rodent;
Keywords: ضدافسردگی; Pharmacoepidemiology; Data linkage; Urban; Antidepressant;